Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC. | Front Immunol | 2023 | 38187374 | PubTator, text mining | PubMed |
| Prognostic Biomarkers in Pituitary Tumours: A Systematic Review. | touchREV Endocrinol | 2023 | 38187082 | PubTator, text mining | PubMed |
| ILC2-mediated immune crosstalk in chronic (vascular) inflammation. | Front Immunol | 2023 | 38179045 | PubTator, text mining | PubMed |
| Selective ablation of thymic and peripheral Foxp3+ regulatory T cell development. | Front Immunol | 2023 | 38164128 | PubTator, text mining | PubMed |
| Comprehensive analysis of mitophagy-related genes in NSCLC diagnosis and immune scenery: based on bulk and single-cell RNA sequencing data. | Front Immunol | 2023 | 38155968 | PubTator, text mining | PubMed |
| Rank aggregation of independent genetic screen results highlights new strategies for adoptive cellular transfer therapy of cancer. | Front Immunol | 2023 | 38143765 | PubTator, text mining | PubMed |
| Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma. | Front Immunol | 2023 | 38143740 | PubTator, text mining | PubMed |
| Phytochemicals as Immunomodulatory Molecules in Cancer Therapeutics. | Pharmaceuticals (Basel) | 2023 | 38139779 | PubTator, text mining | PubMed |
| Farnesol Inhibits PI3 Kinase Signaling and Inflammatory Gene Expression in Primary Human Renal Epithelial Cells. | Biomedicines | 2023 | 38137543 | PubTator, text mining | PubMed |
| Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer. | Cancers (Basel) | 2023 | 38136368 | PubTator, text mining | PubMed |
| Therapeutic Targeting of Glioblastoma and the Interactions with Its Microenvironment. | Cancers (Basel) | 2023 | 38136335 | PubTator, text mining | PubMed |
| Emerging Therapeutic Targets and Drug Resistance Mechanisms in Immunotherapy of Hematological Malignancies. | Cancers (Basel) | 2023 | 38136311 | PubTator, text mining | PubMed |
| Therapeutic Monoclonal Antibodies against Cancer: Present and Future. | Cells | 2023 | 38132155 | PubTator, text mining | PubMed |
| What happens to regulatory T cells in multiple myeloma. | Cell Death Discov | 2023 | 38129374 | PubTator, text mining | PubMed |
| Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. | Elife | 2023 | 38127790 | PubTator, text mining | PubMed |
Comprehensive analysis of single-cell and bulk RNA-sequencing data identifies B cell marker genes signature that predicts prognosis and analysis of immune checkpoints expression in head and neck squamous cell carcinoma. | Heliyon | 2023 | 38125461 | PubTator, text mining | PubMed |
| Non-canonical NFKB signaling endows suppressive function through FOXP3-dependent regulatory T cell program. | Heliyon | 2023 | 38125410 | PubTator, text mining | PubMed |
| The effect of hypothyroidism on the risk of diabetes and its microvascular complications: a Mendelian randomization study. | Front Endocrinol (Lausanne) | 2023 | 38116309 | PubTator, text mining | PubMed |
| IER5L is a Prognostic Biomarker in Pan-Cancer Analysis and Correlates with Immune Infiltration and Immune Molecules in Non-Small Cell Lung Cancer. | Int J Gen Med | 2023 | 38106972 | PubTator, text mining | PubMed |
| Discrepancy in the suppressive function of regulatory T cells in allergic asthmatic vs. allergic rhinitis subjects upon low-dose allergen challenges. | Front Allergy | 2023 | 38106504 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=12